A Study of ORX142 in Healthy Adult Subjects, Including Subjects 18 to 80 Years of Age

Recruiting

Phase 1 — Early testing in a small group of people (usually 20–80) to evaluate safety, determine safe dosage, and identify side effects.

Trial locations(3 sites)

United States

Site #1, Lincoln, Nebraska

Site #2, Eatontown, New Jersey

Site #3, New York, New York